Photodynamic Therapy Derived Personalized Whole Cell Tumor Vaccine Prevents Postsurgery Tumor Recurrence and
Chunyu Yang1, Yitong Jiang2, Kaixin Zhang1
1Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Chemical Resource Engineering, College of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing, 100029, China.
Abstract:
In order to avoid the time-consuming and laborious identification of tumor-specific antigens (TSAs) during the traditional vaccine fabrication process, a versatile photodynamic therapy (PDT)-based method is developed to construct a whole-tumor antigen tumor vaccine (TV) from surgically resected tumor tissues for personalized immunotherapy. Mucoadhesive nanoparticles containing small-molecular photosensitizer are fabricated and directly co-incubated with suspended tumor cells obtained after cytoreduction surgery. After irradiation with a 405 nm laser, potent immunogenic cell death of cancer cells could be induced. Along with the release of TSAs, the as-prepared TV could activate safe and robust tumor-specific immune responses, leading to efficient suppression of postsurgery tumor recurrence and metastasis. The as-prepared TV cannot only be applied alone through various administration routes but also synergize with immunoadjuvant, chemotherapeutics, and immune checkpoint blockers to exert more potent immune responses. This work provides an alternative way to promote the clinical translation of PDT, which is generally restricted by the limited penetration of light. Moreover, the versatile strategy of vaccine fabrication also facilitates the clinical application of personalized whole-cell tumor vaccines.
Insights
A novel photodynamic therapy (PDT) method creates personalized tumor vaccines (TVs) from patient tissues, bypassing antigen identification. This approach effectively suppresses tumor recurrence and metastasis by inducing potent immune responses.
Area of Science:
- Oncology
- Immunology
- Biomedical Engineering
Background:
- Traditional tumor-specific antigen (TSA) identification for vaccine fabrication is time-consuming and labor-intensive.
- Photodynamic therapy (PDT) offers potential for cancer treatment but faces challenges with light penetration.
- Personalized immunotherapy requires efficient and accessible methods for vaccine development.
Purpose of the Study:
- To develop a versatile, photodynamic therapy (PDT)-based method for constructing whole-tumor antigen tumor vaccines (TVs) from resected tumor tissues.
- To enable personalized immunotherapy by bypassing the need for identifying specific tumor antigens (TSAs).
- To investigate the efficacy of the developed TV in suppressing postsurgery tumor recurrence and metastasis.
Main Methods:
- Fabrication of mucoadhesive nanoparticles containing a photosensitizer.
- Co-incubation of nanoparticles with tumor cells obtained from cytoreduction surgery.
- Irradiation with a 405 nm laser to induce immunogenic cell death and TSA release.
Main Results:
- The PDT-based method successfully induced potent immunogenic cell death in cancer cells.
- The prepared tumor vaccines (TVs) released tumor-specific antigens (TSAs), activating robust immune responses.
- The TVs demonstrated efficient suppression of postsurgery tumor recurrence and metastasis.
- The TVs showed synergistic effects when combined with immunoadjuvants, chemotherapeutics, and immune checkpoint blockers.
Conclusions:
- A versatile PDT-based strategy enables the efficient fabrication of personalized whole-cell tumor vaccines, overcoming limitations of traditional methods.
- This approach facilitates the clinical translation of PDT by providing a method for vaccine generation from resected tumor tissue.
- The developed tumor vaccines (TVs) offer a promising platform for personalized immunotherapy, alone or in combination therapies.
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...


